Showing results (2941-2950 of 8,969) with videos related to
Sort By:
Pageof 897
Journal of Hepatology|November 11, 2017
Should we undertake surveillance for HCC in patients with NAFLD?Ramy Younes, Elisabetta BugianesiJournal of Hepatology|November 9, 2017
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver diseaseMarie Boyle, Steven Masson, Quentin M AnsteeJournal of Hepatology|October 10, 2017
Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinomaChetana Lim, Prashant Bhangui, Chady Salloum, et al.Journal of Hepatology|February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general populationGeorge V Papatheodoridis, Vana Sypsa, George Dalekos, et al.Journal of Hepatology|February 11, 2018
Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trialBoris Guiu, Jean-Louis Jouve, Antonin Schmitt, et al.Journal of Hepatology|February 11, 2018
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitorsEleonora De Martin, Jean-Marie Michot, Barbara Papouin, et al.Journal of Hepatology|December 31, 2017
Adult hepatocytes direct liver organogenesis through non-parenchymal cell recruitment in the kidneyRie Utoh, Junji Komori, Hiroyuki Kuge, et al.Journal of Hepatology|November 26, 2018
Evolutionary biology of human hepatitis virusesAndrea Rasche, Anna-Lena Sander, Victor Max Corman, et al.Journal of Hepatology|November 26, 2018
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D'Ambrosio, Luisa Pasulo, Massimo Puoti, et al.Journal of Hepatology|February 27, 2016
The potential of induced pluripotent stem cell derived hepatocytesZara Hannoun, Clara Steichen, Noushin Dianat, et al.Pageof 897